Naftopidil dihydrochloride is a dual antagonist of 5-HT1A and alpha1-adrenergic receptors, exhibiting IC50 values of 0.1 µM and 0.2 µM, respectively. This compound is utilized in research to investigate receptor functions in urological and cardiovascular systems, with applications in both in vitro binding assays and in vivo pharmacological studies.
